Advertisement
Screener

AtriCure, Inc. (ATRC) Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount

3.0 / 5 stars · 59/97 Roast Me

AtriCure, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount

AtriCure, Inc. (ATRC) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of $2.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.

Financial Statements › Expense Statement › Income Tax

us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-02-19

  • AtriCure, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2025 was $2.00M.
Period endEffective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month
2025-12-31$2.00M
10-K · filed 2026-02-19

Similar stocks

Stock NameCountryMarket CapPE Ratio
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
PULSE BIOSCIENCES, INC. (PLSE)United States$3.696B-24.47
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
Heartflow, Inc. (HTFL)United States$4.225B
NovoCure Ltd (NVCR)$1.886B-11.87
LEMAITRE VASCULAR INC (LMAT)United States$1.848B33.37
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14